Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Computational model of CAR T-cell immunotherapy dissects and predicts leukemia patient responses at remission, resistance, and relapse

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-005360Source: DataRank Database

Computational model of CAR T-cell immunotherapy dissects and predicts leukemia patient responses at remission, resistance, and relapse is a research paper published in Journal for ImmunoTherapy of Cancer (2022). On theSindex it has a DataRank of 0. It has been cited 41 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access41 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (16 grants)Impact (FWCI 3.25)OA: goldTopics (34)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Chao Ma ORCID,Zhuoyu Zhang ORCID,Matthew T. Witkowski ORCID,Iannis Aifantis ORCID,Saba Ghassemi ORCID

Live enrichment

PubMed:36600553 OpenAlex:https://openalex.org/W4310747261

Cancer Research Institute

Grant: CRI4018

The Leukemia & Lymphoma Society

Grant: N/A

National Science Foundation

Grant: CBET 2103219

National Institutes of Health

Grant: P01CA229086

National Institutes of Health

Grant: R01CA173636

National Institutes of Health

Grant: R01CA216421

National Institutes of Health

Grant: R01CA228135

National Institutes of Health

Grant: R01CA242020

National Institutes of Health

Grant: R35GM133646

National Institutes of Health

Grant: 5R01CA173636-03

Role of TET2 mutations in malignant transformation and acute myeloid leukemia

National Institutes of Health

Grant: 1R01CA228135-01A1

Mechanisms of enhancer regulation in leukemia

National Institutes of Health

Grant: 1R35GM133646-01

Dissecting and engineering CAR T-cell function for optimized Immunotherapy

National Institutes of Health

Grant: 5R01CA216421-05

The cohesin complex as a tumor suppressor in myeloid leukemia

National Institutes of Health

Grant: 1P01CA229086-01A1

The impact of changes in chromatin architecture on cancer phenotypes and tumor progression

National Institutes of Health

Grant: 5R01CA242020-05

Targeting an RNA Binding Protein Network in Acute Myeloid Leukemia

National Science Foundation

Grant: 2103219

Bioengineering Leukemic Bone Marrow Niche for Dissecting the Heterogeneous Leukemia Chemo-resistance Mechanisms

FWCI

3.25

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by-nc

journalhttps://jitc.bmj.com/content/jitc/10/12/e005360.full.pdf

publisherhttps://jitc.bmj.com/content/jitc/10/12/e005360.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1136/jitc-2022-005360

journalhttps://doi.org/10.1136/jitc-2022-005360

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36600553

Fields of Study

CAR-T cell therapy researchVLSI and FPGA Design TechniquesMonoclonal and Polyclonal Antibodies Research0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Receptors, Chimeric AntigenHumansImmunotherapyLeukemiaRecurrenceT-LymphocytesAntigens, CD19

Keywords

Chimeric antigen receptorCD19MedicineT cellImmunotherapyClinical trialLeukemiaOncologyInternal medicineAntigenImmunologyCancerImmune systemReceptors, Chimeric AntigenImmune Cell Therapies and Immune Cell EngineeringT-LymphocytesAntigens, CD19Neoplasms. Tumors. Oncology. Including cancer and carcinogensRecurrenceHumansRC254-282

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being